GenBio AI Appoints Ziv Bar-Joseph as Co-Founder and Chief Scientific Officer

GenBio AI has announced the appointment of Dr. Ziv Bar-Joseph as Co-Founder and Chief Scientific Officer, announced in a press release. Bar-Joseph will lead the integration and application of GenBio AI's multiscale foundation models, focusing on advancing drug discovery and medical research.

Dr. Bar-Joseph brings a wealth of experience from his previous role at Sanofi, where he led R&D Data and Computational Sciences. He is also a professor at Carnegie Mellon University, specializing in AI applications in genomics and systems biology. His leadership is expected to be pivotal in GenBio AI's mission to develop the first AI-driven Digital Organism (AIDO).

Eric Xing, Co-Founder and Chief Scientist of GenBio AI, expressed enthusiasm about Bar-Joseph's appointment, highlighting his unparalleled expertise in computational biology and AI. GenBio AI aims to revolutionize biological research with its integrated multiscale models, which provide a comprehensive view of biological systems from cells to organs.

With operations in Palo Alto, Abu Dhabi, and Paris, GenBio AI is dedicated to transforming biological research and building platforms to model complex biological systems. The company has published several technical papers on its novel approach to creating the world's first AIDO at the NeurIPS conference.